HSIE Results Daily: Max Healthcare Institute, Mankind Pharma, J Kumar Infraprojects
Max Healthcare Institute: EBITDA^ grew 28% YoY, with 29% YoY sales growth (hospital sales up 29%, acquired/new unit sales at INR 3.9 bn, and Max...
187 Views
Belrise Industries IPO - RHP Updates & Thoughts on Peer Comp and Valuation
Belrise Industries Limited is looking to raise about US$252m in its upcoming India IPO. In this note, we will talk about the IPO valuations.
556 Views
APAC Healthcare Weekly (May 18)-Hengrui Medicine, Wuxi Biologics, Chugai, GC Biopharma, Mayne Pharma
Jiangsu Hengrui launches HK IPO. Wuxi Biologics to sell Germany plant. Chugai got Japan approval for gene therapy. Mayne Pharma was hit as FDA...
589 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an âExecutive Orderâ (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
163 Views
Park Medi World Pre-IPO: Some Points Worth Attention
Park Medi World, the second largest private hospital chain in North India, intends to raise INR9.6B via issuing fresh shares for debt repayment,...
736 Views